Developments and emerging trends in PD-L1 research in gastrointestinal cancers (2000-2018): a bibliometric perspective
Abstract Background: The programmed death-ligand 1 (PD-L1) pathway inhibits T-cell receptor-mediated production of IL-2 and T-cell proliferation and plays an important role in the immunosuppression of various types of cancers. An increasing number of studies have focused on the potential utilization of anti-PD-L1 therapy in gastrointestinal cancers. In this study, we aimed to analyze developments and emerging trends in studies of PD-L1 in gastrointestinal cancers from a bibliometric perspective. Methods: Manuscripts were retrieved from th Web of Science Core Collection (WOSCC) Database. CiteSpace, a bibliometric software, was used to identify landmark studies, key concepts, and various subtopics in this research area. Results: A total of 1325 manuscripts examining PD-L1 in gastrointestinal cancers were included. Manuscripts published in 2017 and 2018 accounted for almost half of the publications (44.2%, 586/1325). Combined with 31,960 references, the manuscripts on this topic constituted a complex co-citation network, and landmark papers were identified by indexes including citation in the network, betweenness centrality, and burstiness . Key concepts such as “Regulatory T cell,” “TIL,” and “Her2” were identified in the co-citation network for author keywords. Furthermore, several subtopics were identified during the process of “clustering” in colorectal, gastroesophageal, and hepatopancreatobiliary cancers, such as “predictive biomarkers”, “advanced cancers”, and “clinical efficacy”. Conclusions: Research on PD-L1 i n gastrointestinal cancers is a rapidly progressing area. More scientific findings are expected in the near future. Analysis and summarization from a bibliometric perspective not onlyidentify landmark manuscripts and hot-spot concepts but also indicate possible directions for future studies.